Repligen
RGEN
#2379
Rank
HK$62.99 B
Marketcap
HK$1,117
Share price
2.45%
Change (1 day)
12.09%
Change (1 year)
Categories

Repligen (RGEN) - Total assets

Total assets on the balance sheet as of March 2026 : HK$22.98 Billion

According to Repligen 's latest financial reports the company's total assets are HK$22.98 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Repligen - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31HK$22.95 B4.47%
2024-12-31HK$21.96 B-0.65%
2023-12-31HK$22.11 B11.79%
2022-12-31HK$19.78 B7.56%
2021-12-31HK$18.38 B24.66%
2020-12-31HK$14.75 B35.28%
2019-12-31HK$10.90 B79.76%
2018-12-31HK$6.06 B4.42%
2017-12-31HK$5.80 B159.29%
2016-12-31HK$2.24 B97.66%
2015-12-31HK$1.13 B13.9%
2014-12-31HK$0.99 B8.16%
2013-12-31HK$0.92 B22.35%
2012-12-31HK$0.75 B
2011-03-31HK$0.56 B1.38%
2010-03-31HK$0.55 B-2.96%
2009-03-31HK$0.57 B6.7%
2008-03-31HK$0.53 B135.8%
2007-03-31HK$0.22 B1.95%
2006-03-31HK$0.22 B3.54%
2005-03-31HK$0.21 B-6.66%
2004-03-31HK$0.23 B10.33%
2003-03-31HK$0.20 B-7.97%
2002-03-31HK$0.22 B-9.43%
2001-03-31HK$0.25 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
HK$1.628 T 6,984.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
HK$888.46 B 3,765.23%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$1.007 T 4,282.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$678.22 B 2,850.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
HK$0.69 B-96.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
HK$8.18 B-64.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$38.47 B 67.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
HK$20.00 B-12.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$67.37 B 193.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
HK$60.62 B 163.76%๐Ÿ‡บ๐Ÿ‡ธ USA